| Volume 19 • Issue 15 |
September 4, 2019 |
|
|
|
|
 |
| |
NEW PRODUCT LAUNCH - Prpdp-AMLODIPINE 1 MG/ML ORAL SOLUTION
|
|
|
Pendopharm is pleased to announce the launch of Prpdp-AMLODIPINE Oral Solution (Amlodipine Besylate), offered in bottes of 150mL. A convenient alternative to pharmacy compounding.
READ MORE
|
 |
|
|
| |
PrEUCRISATM - AVAILABLE TO ORDER
|
|
|
Pfizer Canada is pleased to provide EUCRISA Patient Information. EUCRISA (crisaborole ointment 2%) is available in 60 gram tubes. To access EUCRISA Patient Information,
CLICK HERE
|
 |
|
|
 |
| |
BIKTARVY® IS NOW LISTED ON CANADIAN FORMULARIES
|
|
|
Gilead is pleased to announce that BIKTARVY® is now reimbursed on Alberta, Saskatchewan, Ontario, Quebec and NIHB Formularies. For more information, talk to your Gilead Representative or call 1‑866‑565‑5409.
|
 |
|
|
 |
| |
BUSCOPAN® TABLETS ARE AVAILABLE, WITHOUT PRESCRIPTION, TO TARGET ABDOMINAL CRAMPS, PAIN & DISCOMFORT.
|
|
|
Patients suffering from abdominal cramps, pain & discomfort may not know there is a targeted cramp treatment available without prescription. Consider recommending Buscopan - with a revised indication & updated product monograph, the tablets are now lactose free.
READ MORE
|
 |
|
|
|
|
| |
SOOTHE® RESTORE (ADVANCED DRY EYE THERAPY)
|
|
|
Recommend SOOTHE® RESTORE (ADVANCED DRY EYE THERAPY). 86% of patients with dry eye disease demonstrated signs of Meibomian Gland Dysfunction. Soothe® Restore stabilizes the tear film and helps prevent aqueous evaporation.
READ MORE
|
 |
|
| |
PREVENTION AND TREATMENT OF IRON DEFICIENCY
|
|
|
|
| |
MANY PATIENTS DON’T KNOW ABOUT AVAILABLE NON-PRESCRIPTION OPTIONS FOR ALLERGY SYMPTOM RELIEF
|
|
|
Your patients may not be aware of ALL of the options they have to relieve bothersome allergy symptoms. It’s important for your patients to know all their non-prescription options, so they can choose a product that can manage their symptoms.
READ MORE
|
 |
|
| |
HELPS REDUCE THE CHANCE OF CATCHING A COLD AND FLU
|
|
|
COLD-FX® Daily Support helps reduce the frequency, severity and duration of cold and flus…
READ MORE
|
 |
|
|
|
|
